44 results
424B3
CHRS
Coherus Biosciences Inc
26 Jul 23
Prospectus supplement
4:59pm
include, but are not limited to, delays in the initiation and enrollment of clinical trials, supply chain disruptions, prescriber behavior due to increases
S-4/A
wuyp6nrcdn l9zj0n8
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
sviwyfs2av0
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
m2onoqmthjyfiawa
16 Jun 23
Business combination disclosure
5:17pm
425
prs6v4 9yqki
16 Jun 23
Business combination disclosure
5:16pm
425
hslmt9dg 0ll0f
16 Jun 23
Business combination disclosure
5:14pm
425
1qv5k
16 Jun 23
Business combination disclosure
5:14pm
425
9y5y4v2gel
16 Jun 23
Business combination disclosure
5:12pm
425
v19bf aggpf
16 Jun 23
Business combination disclosure
5:11pm
425
3jur7hnczy38x643z
16 Jun 23
Business combination disclosure
8:08am
425
ua3e11kdvfzqc0
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-99.1
hsmmz057
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
lpmjw91amm1ca vz
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
424B5
k4iaei7j rqpu42fh
17 May 23
Prospectus supplement for primary offering
4:02pm
424B5
u27dyvuzfdpa3h2t0
16 May 23
Prospectus supplement for primary offering
6:07am